A new x-ray activated nanoparticle photosensitizer for cancer treatment

Journal of Biomedical Nanotechnology

Volumn 10, Issue 8, 2014, Pages 1501-1508

  Ma, Lun ^a   Zou, Xiaoju ^a   Chen, Wei ^a  

^a UNIVERSITY OF TEXAS AT ARLINGTON   (United States)

Author keywords

Cancer; Copper Cysteamine complex; Nanoparticles; Penetration; Photodynamic therapy; Radiotherapy; Singlet oxygen; X Ray activation

Indexed keywords

COPPER; COPPER COMPOUNDS; DISEASES; NANOPARTICLES; OXYGEN; PHOTODYNAMIC THERAPY; RADIOTHERAPY; TISSUE; X RAYS;

CANCER; COPPER-CYSTEAMINE COMPLEX; PENETRATION; SINGLET OXYGEN; X-RAY ACTIVATIONS;

PHOTOSENSITIZERS;

COPPER CYSTEAMINE; NANOPARTICLE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER THERAPY; CELL DESTRUCTION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PHOTODYNAMIC THERAPY; PHOTOLUMINESCENCE; X RAY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; COPPER; CYSTAMINE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; METAL NANOPARTICLES; MICE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SINGLET OXYGEN; X-RAYS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84899696191     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1954     Document Type: Article

References (41)

1. R. Singh and H. S. Nalwa, Medical applications of nanoparticles in biological imaging, cell labeling, antimicrobial agents, and anticancer nanodrugs. J. Biomed. Nanotechnol. 7, 489 (2011).
2. A. M. Cherian, S. V. Nair, and V. K. Lakshmanan, The role of nanotechnology in prostate cancer theranostic applications. J. Nanosci. Nanotechnol. 14, 841 (2014).
3. S. Elingarami, M. Liu, J. Fan, and N. He, Applications of nanotechnology in gastric cancer: Detection and prevention by nutrition. J. Nanosci. Nanotechnol. 14, 932 (2014).
4. J. F. Liao, T. T. Qi, B. Y. Chu, J. R. Peng, F. Luo, and Z. Y. Qian, Multifunctional nanostructured materials for multimodal cancer imaging and therapy. J. Nanosci. Nanotechnol. 14, 175 (2014).
5. M. Lin, J. Huang, and M. Sha, Recent advances in nanosized Mn-Zn ferrite magnetic fluid hyperthermia for cancer treatment. J. Nanosci. Nanotechnol. 14, 792 (2014).
6. A. P. Pandey, N. M. Girase, M. D. Patil, P. O. Patil, D. A. Patil, and P. K. Deshmukh, Nanoarchitectonics in cancer therapy and imaging diagnosis. J. Nanosci. Nanotechnol. 14, 828 (2014).
7. Y. Saadeh, T. Leung, A. Vyas, L. S. Chaturvedi, O. Perumal, and D. Vyas, Applications of nanomedicine in breast cancer detection, imaging, and therapy. J. Nanosci. Nanotechnol. 14, 913 (2014).
8. M. Bottini, C. Sacchetti, A. Pietroiusti, S. Bellucci, A. Magrini, N. Rosato, and N. Bottini, Targeted nanodrugs for cancer therapy: Prospects and challenges. J. Nanosci. Nanotechnol. 14, 98 (2014).
9. I. Macdonald and T. Dougherty, Basic principles of photodynamic therapy. J. Porphyrines Phthalocyanines 5, 105 (2001).
10. H. I. Pass, Photodynamic therapy in oncology: Mechanisms and clinical use. J. National Cancer Institute 85, 443 (1993).
11. C. M. Moore, D. Pendse, and M. Emberton, Photodynamic therapy for prostate cancer-A review of current status and future promise. At Clin. Pract. Urol. 6, 18 (2009).
12. H. Lepor, Vascular targeted photodynamic therapy for localized prostate cancer. Rev. Urol. 10, 254 (2008).
13. A. Feofanov, A. Grichine, T. Karmakova, A. Pljutinskaya, V. Lebedeva, A. Filyasova, R. Yakubovskaya, A. Mironov, M. Egret-Charlier, and P. Vigny, Near-infrared Photosensitizer Based on a Cycloimide Derivative of Chlorin p6: 13,15-N-(39-Hydroxypropyl) Cycloimide Chlorin p6. Photochem. Photobiol. 75, 633 (2002).
14. J. P. Rovers, M. L. d. Jode, and M. F. Grahn, Significantly Increased Lesion Size by Using the Near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue. Laser Surg. Med. 27, 235 (2000).
15. J. P. Rovers, M. L. d. Jode, H. Rezzoug, and M. F. Grahn, In vivo photodynamic characteristics of the near-infrared photosensitizer 5,10,15,20-tetrakis(M-hydroxyphenyl)bacteriochlorin. Photochem. Photobiol. 72, 358 (2000).
16. G. Al-Sayyed, J. C. D'Oliveira, and P. Pichat, Semiconductorsensitized photodegradation of 4-chlorophenol in water. J. Photochem. Photobiol. A 58, 99 (1991).
17. H. S. Nalwa, (ed.), Encyclopedia of Nanoscience and Nanotechnology, American Scientific Publishers, Los Angeles, CA (2004/2011), Vols. 1-25.
18. H. Weller, Optical Properties of quantized semiconductor particles. Philos. T. R. Soc. A 354, 757 (1996).
19. B. C. Wilson, Photodynamic Therapy for cancer: Principles. Can. J. Gastroenterol. 16, 393 (2002).
20. H. Guo, H. Qian, N. M. Idris, and Y. Zhang, Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomedicine: Nanotechnol. Biol. Med. 6, 486 (2010).
21. B. Ungun, R. K. Prud'homme, S. J. Budijono, J. Shan, S. F. Lim, Y. Ju, and R. Austin, Nanofabricated upconversion nanoparticles for photodynamic therapy. Opt. Express 17, 80 (2009).
22. C. Wang, H. Tao, L. Cheng, and Z. Liu, Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 32, 6145 (2011).
23. Y. Zhang and N. M. Idris, Enhanced photodynamic therapy using NIR-to-visible upconversion fluorescent nanoparticles. Photodiagn. Photodyn. 8, 158 (2011).
24. W. Chen, Nanoparticle self-lighting photodynamic therapy for cancer treatment. J. Biomed. Nanotechnol. 4, 369 (2008).
25. P. Juzenas, W. Chen, Y.-P. Sun, M. Coelho, R. Generalov, N. Generalova, and I. Christensen, Quantum dots and nanoparticles for photodynamic and radiotherapy of cancer. Adv. Drug Deliv. Rev. 60, 1600 (2008).
26. X. Zou, M. Yao, L. Ma, M. Hossu, W. Chen, X. Han, and P. Juzenas, X-ray induced nanoparticles based photodynamic therapy of cancer. Nanomedicine (2014), doi:10.2217/NNM.13.198.
27. Y. F. Liu, W. Chen, S. P. Wang, Y. B. Zhang, and C. Pope, Optical behaviors of ZnO-porphyrin nanoconjugates and their potential applications for cancer treatment. Appl. Phys. Lett. 92, 143901 (2008).
28. Y. Zhang, W. Chen, S. Wang, Y. Liu, and C. Pope, Phototoxicity of Zinc oxide nanoparticleconjugates in human ovarian cancer NIH: OVCAR-3 cells. J. Biomed. Nanotechnol. 4, 432 (2008).
29. F. Liu, W. Chen, S. P. Wang, and A. G. Joly, Investigation of watersoluble X-ray luminescence nanoparticles for photodynamic activation. Appl. Phys. Lett. 92, 43901 (2008).
30. W. Chen and J. Zhang, Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 6, 1159 (2006).
31. M. Fakhar-e-Alam, S. Kishwar, M. Siddique, M. Atif, O. Nur, and M. Willander, The photodynamic effect of ZnO nanorods and their ligands with different photosensitizers. Rev. Nanosci. Nanotechnol. 1, 40 (2012).
32. H.-M. Chiang, Q. Xia, X. Zou, C. Wang, S. Wang, B. J. Miller, P. C. Howard, J. J. Yin, F. A. Beland, H. Yu, and P. P. Fu, Nano-ZnO induces cytotoxicity and DNA damage in human cell lines and rat primary neuronal cells. J. Nanosci. Nanotechnol. 12, 2126 (2012).
33. S. Dhara and P. K. Giri, ZnO nanowire heterostructures: Intriguing photophysics and emerging applications. Rev. Nanosci. Nanotechnol. 2, 147 (2013).
34. N. Rozanova and J. Z. Zhang, Metal and magnetic nanostructures for cancer diagnosis and therapy. Rev. Nanosci. Nanotechnol. 2, 29 (2013).
35. L. Ma, W. Chen, G. Schatte, W. Wang, A. G. Joly, Y. Huang, R. Sammynaiken, and M. Hossu, A new Cu-cysteamine complex: Structure and optical properties. J. Mater. Chem. C (2014), (submitted).
36. I. Kraljić and S. E. Mohsni, A new method for the detection of singlet oxygen in aqueous solutions. Photochem. Photobiol. 28, 577 (1978).
37. Cancer Facts and Figures, American Cancer Society, http://www.cancer.org/ research/cancerfactsstatistics/cancerfactsfigures2013/index, (2013).
38. A. B. Mariotto, K. Robin Yabroff, Y. Shao, E. J. Feuer, and M. L. Brown, Projections of the cost of cancer care in the United States: 2010-2020. J. National Cancer Institute 103, 117 (2011).
39. S. Guo and L. Huang, Nanoparticles escaping RES and endosome: Challenges for siRNA delivery for cancer therapy. J. Nanomater. 2011, 1 (2011).
40. K. S. Yadav, K. Chuttani, A. K. Mishra, and K. K. S. KK, PDA Effect of size on the biodistribution and blood clearance of etoposide-loaded PLGA nanoparticles. J. Pharm. Sci. Technol. 65, 131 (2011).
41. S. Bamrungsap, Z. Zhao, T. Chen, L. Wang, C. Li, T. Fu, and W. Tan, Nanotechnology in therapeutics: A focus on nanoparticles as a drug delivery system. Nanomedicine 7, 1253 (2012).